Shingleton W B, Blalock J, Clark J, Bigler S A
University of Mississippi Medical Center, Jackson, USA.
J Miss State Med Assoc. 1998 Mar;39(3):86-9.
To determine prevalence of renal cell carcinoma in a cohort of patients with end stage renal disease who underwent nephrectomies for suspicious cysts or masses.
A retrospective review of patients with end stage renal disease who were receiving hemodialysis and underwent nephrectomies were identified and those charts were reviewed.
Twenty patients, from a total of 400 patients with end stage renal disease, had nephrectómies preformed for various reasons. Of these twenty patients, four were found to have renal cell carcinoma with an occurrence rate of 5% in these patients. At followup from 1-9 years, all patients are alive without evidence of disease.
Patients with end stage renal disease have an increased prevalence of renal cell carcinoma. While the patients in this series have a 100% survival at 1-9 year follow-up, the overall survival rate in published reports is 35%. The need is to identify patients at high risk for the development of this disease and perform annual screening.
确定因可疑囊肿或肿块接受肾切除术的终末期肾病患者队列中肾细胞癌的患病率。
对接受血液透析且接受肾切除术的终末期肾病患者进行回顾性研究,并查阅这些患者的病历。
在总共400例终末期肾病患者中,有20例因各种原因接受了肾切除术。在这20例患者中,有4例被发现患有肾细胞癌,这些患者的发生率为5%。在1至9年的随访中,所有患者均存活且无疾病证据。
终末期肾病患者肾细胞癌的患病率增加。虽然本系列患者在1至9年随访中的生存率为100%,但已发表报告中的总体生存率为35%。需要识别出患此病风险高的患者并进行年度筛查。